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• Delayed gastric emptying affects a substantial proportion of patients with long-standing diabetes, and when associated with symptoms and/or disordered glycemic control, affects quality of life adversely.
• On the other hand changes in gastric incretin hormones also play an important role in the pathophysiology of diabetes.
• In our study, we aimed to investigate the incidence of gastrointestinal disease in patients with newly diagnosed diabetes and pre-diabetes.
• A total of 73 patients with new diagnosed pre-diabetes and diabetes were included in the study. Patients demographic data, biochemical parameters and glycemic control data were recorded.
• Patients were examined in detail, gastrointestinal disorders (peptic ulcer, gastritis, gastro esophageal reflux, functional dyspepsia, functional bowel disease, organic bowel disease) and gastrointestinal medications were recorded.
• Furthermore, during admission, a questionnaire for gastrointestinal disease; gastrointestinal symptoms rating scale (GSRS) was performed.
Data were compared in patients with pre-diabetes and diabetes.
• Mean age of diabetic patients (n = 39) was 47.6 ± 8.7 while 39.8 ± 14.6 of pre-diabetic patients (n=34) (p = 0.009), and mean HbA1c levels were found 7.8 ± 1.9 in patients with diabetes, 5.8 ± 0.4 in patients with pre-diabetes (p<0.001).
• Fasting blood glucose (FBG), postprandial blood glucose (PBG) and creatinin levels were higher in patients with diabetes compared to prediabetes (FBG 156.7 & 99.4, PBG 230.7 & 143.2, creatinin 0.8 & 0.6 ).
The average total GSRS scores were 5.95 ± 3.9 and 4.59 ± 4.2 in patients with diabetes and pre-diabetes respectively (p=0.09).
In patients with long standing diabetes, gastroparesis, is a known complication. However, in our study, presence of gastrointestinal diseases was significantly higher in patients with newly diagnosed diabetes when compared with pre-diabetic patients. When also considering incretin hormone effect, contributing of gastrointestinal diseases to the development of diabetes maybe become obvious. • The frequency of gastrointestinal diseases were 38.5% in diabetic patients and 11.8% in the prediabetics (p=0.009). Gastrointestinal drug use (GIDuse) were observed in 20.5% of diabetics and 5.9% of prediabetics (p=0.060).
• No correlation was detected with the presence of gastro-intestinal disease between age, biochemical parameters, HbA1c level or BMI.
